CompletedPhase 2NCT00694941
A Phase II Multi-centre, Extension Study to Investigate the Long Term Safety of ONO-2506PO in Patients Diagnosed With Amyotrophic Lateral Sclerosis (ALS)
Studying Amyotrophic lateral sclerosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Ono Pharmaceutical Co. Ltd
- Principal Investigator
- Tomohiro KuwayamaOno Pharma UK
- Intervention
- ONO-2506PO(drug)
- Enrollment
- 15 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2008
Study locations (25)
- Prof. Maloteaux, UCL Saint-Luc, Brussels, Belgium
- Prof. Wim Robberecht, UZ Leuven, Leuven, Belgium
- Prof. Alain Destee, Hopital Roger Salengro - Clinique Neurologique, Neurologie A, Lille, France
- Prof. Philippe Couratier, Hopital Duruytren, Limoges, France
- Prof. Jan Pouget, Hopital de la Timone, Marseille, France
- Prof. William Camu, Hopital de Chauliac, Montpellier, France
- Prof. Claude Desnuelle, Hopital 1-Archet 1, Nice, France
- Prof. Vincent Meininger, Hopital LaPitie Salpetriere, Paris, France
- Dr. Thomas Meyer, Charite Campus Virchow, ALS Ambulanz, Berlin, Germany
- Prof. Torsten Grehl, Neurologische Ambulanz Universitatsklinik Bergmannsheil, Bochum, Germany
- Professor Dieter Heuss, Poliklinik der Universitat Erlangen-Nurnberg, Neurologische Klinik, Erlangen, Germany
- Prof. Stephan Zierz, Martin Luther Universitat Halle-Wittenberg, Klinikum der Medizinischen Fakultat, Universitatsklinik und Poliklinik fur Neurologie, Halle, Germany
- Prof. Reinhard Dengler, Medizinische Hochschule Hannover, Neurologische Klinik, Hanover, Germany
- Prof Gian Domenico Borasio, Interdisziplinares Zentrum fur Palliativmedizin, München, Germany
- Prof. Albert Ludolph, Klinik und Poliklinikfur Neurologie der Universitat Ulm-Univeritatsklinikum Ulm, Ulm, Germany
- +10 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00694941 on ClinicalTrials.govOther trials for Amyotrophic lateral sclerosis
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07401186Stimulation-Based Modulation of Spinal and Cortical Sensory PathwaysPeter C. Gerszten, MD
- RECRUITINGNCT07467187Invasive Home Ventilation in DenmarkRigshospitalet, Denmark
- RECRUITINGNCT07502677Diagnostic Accuracy of SleepImage Technology for Detecting Respiratory Failure in Patients With Amyotrophic Lateral SclerosisRoyal Brompton & Harefield NHS Foundation Trust
- RECRUITINGNANCT07446114Functional Outcomes and Control Using Synchron BCI - CanadaSynchron, Inc.
- ENROLLING BY INVITATIONPHASE2, PHASE3NCT07410806HEALEY ALS Platform Trial - Regimen I NUZ-001Merit E. Cudkowicz, MD
- ENROLLING BY INVITATIONNANCT07298486Impact of Robotic Glove Use on Quality of Life, Grip Strength and Fine Motor Control in ALSNova Southeastern University
- ACTIVE NOT RECRUITINGPHASE1NCT07204977Acamprosate in C9orf72 Hexanucleotide Repeat Expansion Amyotrophic Lateral Sclerosis (ACALS)National Institute of Neurological Disorders and Stroke (NINDS)
- RECRUITINGPHASE3NCT07322003Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALSPrilenia